Goldman Sachs Assumes Arrowhead Pharma (ARWR) at Neutral

September 24, 2026 5:00 AM EDT Send to a Friend
(Updated - September 24, 2026 5:33 AM EDT)

Goldman Sachs analyst Andrea Newkirk assumes coverage on Arrowhead Pharma (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login